Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
出版年份 2021 全文链接
标题
Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
作者
关键词
ASO, siRNA, miRNA, Aptamer, mRNA, gRNA
出版物
PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages 107967
出版商
Elsevier BV
发表日期
2021-08-14
DOI
10.1016/j.pharmthera.2021.107967
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The growth of siRNA-based therapeutics: updated clinical studies
- (2021) M. May Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients
- (2021) Maria A. Bruusgaard‐Mouritsen et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Lumasiran: First Approval
- (2021) Lesley J. Scott et al. DRUGS
- The century of mRNA vaccines: COVID-19 vaccines and allergy
- (2021) NR Ortega Rodríguez et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Management of late onset urea cycle disorders—a remaining challenge for the intensivist?
- (2021) S. Redant et al. Annals of Intensive Care
- Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation
- (2021) Ludger Klimek et al. ALLERGY
- Non-coding RNAs: Emerging from the discovery to therapeutic applications
- (2021) B. Baptista et al. BIOCHEMICAL PHARMACOLOGY
- CRISPR Takes the Front Seat in CART-Cell Development
- (2021) Claudia Manriquez-Roman et al. BIODRUGS
- Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
- (2021) Dami A. Collier et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients
- (2021) Katarina D. Kovacevic et al. Scientific Reports
- COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee
- (2021) Paul J. Turner et al. World Allergy Organization Journal
- Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions
- (2021) Mitchell M. Pitlick et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Casimersen: First Approval
- (2021) Matt Shirley DRUGS
- Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
- (2021) Suzan M Hammond et al. EMBO Molecular Medicine
- Endosomal escape cell-penetrating peptides significantly enhance pharmacological effectiveness and CNS activity of systemically administered antisense oligonucleotides
- (2021) Mohadeseh Dastpeyman et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
- (2021) Sander F. Garrelfs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
- (2021) Kirill V. Kalnin et al. npj Vaccines
- Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military
- (2021) Jay Montgomery et al. JAMA Cardiology
- Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination
- (2021) Han W. Kim et al. JAMA Cardiology
- Systemic Brain Delivery of Antisense Oligonucleotides across the Blood-Brain Barrier with a Glucose-Coated Polymeric Nanocarrier
- (2020) Hyun Su Min et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Novel approaches for efficient in vivo fermentation production of noncoding RNAs
- (2020) Ai-Ming Yu et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Golodirsen: First Approval
- (2020) Young-A Heo DRUGS
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- The promise and challenge of therapeutic genome editing
- (2020) Jennifer A. Doudna NATURE
- Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
- (2020) Diane E. Frank et al. NEUROLOGY
- Cell Penetrating Peptides, Novel Vectors for Gene Therapy
- (2020) Rebecca E. Taylor et al. Pharmaceutics
- Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
- (2020) David S. Hong et al. BRITISH JOURNAL OF CANCER
- MTL-CEBPA, a small activating RNA therapeutic up-regulating C/EBP-α, in patients with advanced liver cancer: a first-in-human, multi-centre, open-label, phase I trial
- (2020) Debashis Sarker et al. CLINICAL CANCER RESEARCH
- How We Think about Targeting RNA with Small Molecules
- (2020) Matthew G. Costales et al. JOURNAL OF MEDICINAL CHEMISTRY
- Potent and rapid reversal of the von Willebrand Factor Inhibitor Aptamer BT200
- (2020) Shuhao Zhu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
- (2020) You Lu et al. NATURE MEDICINE
- RNA delivery by extracellular vesicles in mammalian cells and its applications
- (2020) Killian O’Brien et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- The powerful world of antisense oligonucleotides: From bench to bedside
- (2020) Anaïs M. Quemener et al. Wiley Interdisciplinary Reviews-RNA
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
- (2020) Paula R. Clemens et al. JAMA Neurology
- Lipid nanoparticles for nucleic acid delivery: Current perspectives
- (2020) Eleni Samaridou et al. ADVANCED DRUG DELIVERY REVIEWS
- Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
- (2020) Gergely Tibor Kozma et al. ADVANCED DRUG DELIVERY REVIEWS
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- Advances in oligonucleotide drug delivery
- (2020) Thomas C. Roberts et al. NATURE REVIEWS DRUG DISCOVERY
- Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
- (2020) Manisha Balwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risdiplam: First Approval
- (2020) Sohita Dhillon DRUGS
- mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
- (2020) Gal Cafri et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
- (2020) Ai-Ming Yu et al. PHARMACOLOGICAL REVIEWS
- Allergic reactions to the first COVID‐19 vaccine: a potential role of Polyethylene glycol?
- (2020) Beatriz Cabanillas et al. ALLERGY
- RNA-binding proteins in human genetic disease
- (2020) Fátima Gebauer et al. NATURE REVIEWS GENETICS
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Next-Generation CRISPR Technologies and Their Applications in Gene and Cell Therapy
- (2020) M. Alejandra Zeballos C. et al. TRENDS IN BIOTECHNOLOGY
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
- (2020) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
- (2020) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Cyclodextrin based natural nanostructured carbohydrate polymers as effective non-viral siRNA delivery systems for cancer gene therapy
- (2020) Hanieh Mousazadeh et al. JOURNAL OF CONTROLLED RELEASE
- Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy
- (2020) Mohsan Iftikhar et al. PHARMACOLOGY & THERAPEUTICS
- Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
- (2019) Alexandros Papachristofilou et al. Journal for ImmunoTherapy of Cancer
- Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
- (2019) Eliane Sardh et al. NEW ENGLAND JOURNAL OF MEDICINE
- mRNA: A Novel Avenue to Antibody Therapy?
- (2019) Thomas Schlake et al. MOLECULAR THERAPY
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- How mRNA therapeutics are entering the monoclonal antibody field
- (2019) Lien Van Hoecke et al. Journal of Translational Medicine
- Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia
- (2019) Shuqian Xu et al. BLOOD
- Therapeutic Antisense Oligonucleotides Are Coming of Age
- (2019) C. Frank Bennett Annual Review of Medicine
- Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
- (2019) Michael Steurer et al. HAEMATOLOGICA
- Overexpression system for recombinant RNA in Corynebacterium glutamicum using a strong promoter derived from corynephage BFK20
- (2019) Shuhei Hashiro et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- CRISPR/Cas system for genome editing: progress and prospects as a therapeutic tool
- (2019) Deepak Kumar Sahel et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
- (2019) Kimberly J. Hassett et al. Molecular Therapy-Nucleic Acids
- Antisense Oligonucleotide Therapies for Neurodegenerative Diseases
- (2019) C. Frank Bennett et al. Annual Review of Neuroscience
- A New Era for Rare Genetic Diseases: Messenger RNA Therapy
- (2019) Paolo G.V. Martini et al. HUMAN GENE THERAPY
- Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure‐Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin‐Mediated (hATTR) Amyloidosis
- (2019) Xiaoping Zhang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives
- (2019) Inés Serrano-Sevilla et al. MOLECULES
- Cancer the‘RBP’eutics–RNA-binding proteins as therapeutic targets for cancer
- (2019) Shakur Mohibi et al. PHARMACOLOGY & THERAPEUTICS
- Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice
- (2019) Arnaud F. Klein et al. JOURNAL OF CLINICAL INVESTIGATION
- Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating Peptide
- (2019) Davide Schiroli et al. Molecular Therapy-Nucleic Acids
- Construction of Corynebacterium glutamicum cells as containers encapsulating dsRNA overexpressed for agricultural pest control
- (2019) Shuhei Hashiro et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Peptide nucleic acid (PNA) and its applications in chemical biology, diagnostics, and therapeutics
- (2019) Jacques Saarbach et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- The recent progresses in shRNA-nanoparticle conjugate as a therapeutic approach
- (2019) Rituparna Acharya Materials Science & Engineering C-Materials for Biological Applications
- Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics
- (2019) Wanrong Yi et al. Acta Pharmaceutica Sinica B
- Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis
- (2019) Teresa Coelho et al. JOURNAL OF NEUROLOGY
- Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran
- (2019) Pedro Renato de Paula Brandão et al. Molecular Diagnosis & Therapy
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- Molecular Mechanism and Evolution of Nuclear Pre-mRNA and Group II Intron Splicing: Insights from Cryo-Electron Microscopy Structures
- (2018) Wojciech P. Galej et al. CHEMICAL REVIEWS
- Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
- (2018) Pui Yan Ho et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Adventures with RNA graphs
- (2018) Tamar Schlick METHODS
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer
- (2018) Vikash Reebye et al. ONCOGENE
- Cell-penetrating peptides for siRNA delivery to glioblastomas
- (2018) Artita Srimanee et al. PEPTIDES
- GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
- (2018) Aaron D. Springer et al. Nucleic Acid Therapeutics
- Aptamers in the Therapeutics and Diagnostics Pipelines
- (2018) Harleen Kaur et al. Theranostics
- Inotersen: First Global Approval
- (2018) Susan J. Keam DRUGS
- Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection
- (2018) Lorna Leal et al. AIDS
- RNA therapy: Are we using the right molecules?
- (2018) Ai-Ming Yu et al. PHARMACOLOGY & THERAPEUTICS
- Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression
- (2018) Xin Li et al. Acta Pharmaceutica Sinica B
- Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models
- (2018) Mei-Juan Tu et al. CANCER LETTERS
- Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery
- (2017) Pascal Röthlisberger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
- (2017) Michael J. Wagner et al. MOLECULAR CANCER THERAPEUTICS
- Propionyl-CoA carboxylase – A review
- (2017) Parith Wongkittichote et al. MOLECULAR GENETICS AND METABOLISM
- Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer
- (2017) Jon Voutila et al. MOLECULAR THERAPY
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
- (2017) Sushrut Kamerkar et al. NATURE
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Aptamers as targeted therapeutics: current potential and challenges
- (2017) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- N1-methyl-pseudouridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density
- (2017) Yuri V. Svitkin et al. NUCLEIC ACIDS RESEARCH
- Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
- (2017) Jayaprakash K. Nair et al. NUCLEIC ACIDS RESEARCH
- Exosomes: Therapy delivery tools and biomarkers of diseases
- (2017) Lucio Barile et al. PHARMACOLOGY & THERAPEUTICS
- Cell-Penetrating Peptides: From Basic Research to Clinics
- (2017) Giulia Guidotti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
- (2017) Hichem Tasfaout et al. Nature Communications
- FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides
- (2017) Annemieke Aartsma-Rus Nucleic Acid Therapeutics
- High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA
- (2017) Junxiao Ye et al. Theranostics
- CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice
- (2017) Yu Zhang et al. Science Advances
- Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review
- (2017) Ahmed M. Al-Abd et al. Journal of Advanced Research
- Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer
- (2016) Tianzhi Yang et al. AAPS Journal
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis
- (2016) James S. Butler et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides
- (2016) Elizabeth J. Ackermann et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Injection site reactions after subcutaneous oligonucleotide therapy
- (2016) Leonie van Meer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Immediate-type hypersensitivity to polyethylene glycols: a review
- (2016) E. Wenande et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Pseudouridine: the fifth RNA nucleotide with renewed interests
- (2016) Xiaoyu Li et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Eteplirsen: First Global Approval
- (2016) Yahiya Y. Syed DRUGS
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Approving a Problematic Muscular Dystrophy Drug
- (2016) Aaron S. Kesselheim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems
- (2016) Mehdi Rezaee et al. JOURNAL OF CONTROLLED RELEASE
- Structural Analysis of Human Argonaute-2 Bound to a Modified siRNA Guide
- (2016) Nicole T. Schirle et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria
- (2016) Abigail Liebow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice
- (2016) Cy A Stein MOLECULAR THERAPY
- Splice-switching antisense oligonucleotides as therapeutic drugs
- (2016) Mallory A. Havens et al. NUCLEIC ACIDS RESEARCH
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment
- (2016) James R. Kintzing et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Bioengineering of noncoding RNAs for research agents and therapeutics
- (2016) Pui Yan Ho et al. Wiley Interdisciplinary Reviews-RNA
- From selection hits to clinical leads: progress in aptamer discovery
- (2016) Keith E Maier et al. Molecular Therapy-Methods & Clinical Development
- siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
- (2015) Shigeo Matsuda et al. ACS Chemical Biology
- Mechanisms and Regulation of Alternative Pre-mRNA Splicing
- (2015) Yeon Lee et al. Annual Review of Biochemistry
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments
- (2015) Yoshiki Sekijima JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- mRNA: Fulfilling the Promise of Gene Therapy
- (2015) Drew Weissman et al. MOLECULAR THERAPY
- Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
- (2015) Ayal Hendel et al. NATURE BIOTECHNOLOGY
- Toll-like receptor 8 senses degradation products of single-stranded RNA
- (2015) Hiromi Tanji et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides
- (2015) Kim A. Lennox et al. NUCLEIC ACIDS RESEARCH
- A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications
- (2015) Qiu-Xia Chen et al. NUCLEIC ACIDS RESEARCH
- Synthetic CRISPR RNA-Cas9–guided genome editing in human cells
- (2015) Meghdad Rahdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- RNA quaternary structure and global symmetry
- (2015) Christopher P. Jones et al. TRENDS IN BIOCHEMICAL SCIENCES
- Toll-like receptor 8 senses degradation products of single-stranded RNA
- (2015) Hiromi Tanji et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- SNS01-T Modulation of eIF5A Inhibits B-cell Cancer Progression and Synergizes With Bortezomib and Lenalidomide
- (2014) Sarah M Francis et al. MOLECULAR THERAPY
- Towards a therapy for Angelman syndrome by targeting a long non-coding RNA
- (2014) Linyan Meng et al. NATURE
- CRISPR-mediated direct mutation of cancer genes in the mouse liver
- (2014) Wen Xue et al. NATURE
- Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates
- (2014) Trinna L. Cuellar et al. NUCLEIC ACIDS RESEARCH
- Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
- (2014) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNAi Factors Are Present and Active in Human Cell Nuclei
- (2014) Keith T. Gagnon et al. Cell Reports
- Multifunctional polymeric micelles for delivery of drugs and siRNA
- (2014) Aditi M. Jhaveri et al. Frontiers in Pharmacology
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles
- (2013) T. Kanazawa et al. BIOMATERIALS
- Chitosan-based siRNA delivery systems
- (2013) Héloïse Ragelle et al. JOURNAL OF CONTROLLED RELEASE
- Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
- (2013) Gregory S. Thomas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
- (2013) Martin A Maier et al. MOLECULAR THERAPY
- RNA catalyses nuclear pre-mRNA splicing
- (2013) Sebastian M. Fica et al. NATURE
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNA
- (2013) Daisuke Mashiko et al. Scientific Reports
- Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles
- (2013) Barbara L Mui et al. Molecular Therapy-Nucleic Acids
- Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery
- (2012) Yin Ren et al. ACS Nano
- Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy
- (2012) Elizabeth J. Ackermann et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
- (2012) Muthusamy Jayaraman et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases
- (2012) Meenakshi Malhotra et al. BIOMATERIALS
- Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B
- (2012) Stanley T. Crooke et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer
- (2012) Phuong Khanh Morrow et al. CANCER
- The Structure of Human Argonaute-2 in Complex with miR-20a
- (2012) Elad Elkayam et al. CELL
- RNA-Based Therapeutics: Current Progress and Future Prospects
- (2012) John C. Burnett et al. CHEMISTRY & BIOLOGY
- Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia
- (2012) Evan A. Stein et al. CIRCULATION
- Identification of modifications in microbial, native tRNA that suppress immunostimulatory activity
- (2012) Stefanie Gehrig et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation
- (2012) Delai Chen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Landscape of transcription in human cells
- (2012) Sarah Djebali et al. NATURE
- RNA therapeutics: beyond RNA interference and antisense oligonucleotides
- (2012) Ryszard Kole et al. NATURE REVIEWS DRUG DISCOVERY
- The Crystal Structure of Human Argonaute2
- (2012) N. T. Schirle et al. SCIENCE
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Cell-penetrating peptides: breaking through to the other side
- (2012) Erez Koren et al. TRENDS IN MOLECULAR MEDICINE
- Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering
- (2012) Jesper B. Bramsen et al. Frontiers in Genetics
- mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients
- (2011) Ellen Van Gulck et al. AIDS
- Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum
- (2011) Liutao Du et al. HUMAN MOLECULAR GENETICS
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
- (2011) Yimin Hua et al. NATURE
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Single-pot enzymatic synthesis of Dicer-substrate siRNAs
- (2011) Keelan Z. Guiley et al. NUCLEIC ACIDS RESEARCH
- A brilliant disguise for self RNA: 5’-end and internal modifications of primary transcripts suppress elements of innate immunity
- (2011) Subba Rao Nallagatla et al. RNA Biology
- An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4+ T Cell Decline in Humanized Mice
- (2011) C. P. Neff et al. Science Translational Medicine
- Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
- (2010) Katrin Knop et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Discovery and Development of Therapeutic Aptamers
- (2010) P.R. Bouchard et al. Annual Review of Pharmacology and Toxicology
- The Promise of MicroRNA Replacement Therapy
- (2010) A. G. Bader et al. CANCER RESEARCH
- Gene silencing efficiency of siRNA-PEG conjugates: Effect of PEGylation site and PEG molecular weight
- (2010) Sooyeon Jung et al. JOURNAL OF CONTROLLED RELEASE
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials
- (2010) Linda J. Popplewell et al. NEUROMUSCULAR DISORDERS
- Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
- (2010) Bart R. Anderson et al. NUCLEIC ACIDS RESEARCH
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses
- (2009) Hideyuki Yanai et al. NATURE
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100
- (2008) Rosie Z. Yu et al. BIOCHEMICAL PHARMACOLOGY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
- (2008) Mark E. Kleinman et al. NATURE
- MicroRNA-373 induces expression of genes with complementary promoter sequences
- (2008) R. F. Place et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started